Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, 20 College Road, Singapore, 169856, Singapore.
Duke-National University of Singapore (NUS) Medical School Singapore, 8 College Road, Singapore, 169857, Singapore.
World J Surg. 2020 Dec;44(12):4197-4206. doi: 10.1007/s00268-020-05713-w. Epub 2020 Aug 28.
Liver resection (LR) is the main modality of treatment for hepatocellular carcinoma (HCC) and colorectal liver metastasis (CRLM). Post-hepatectomy liver failure (PHLF) remains the most dreaded complication. We aim to create a prognostic score for early risk stratification of patients undergoing LR.
Clinical and operative data of 472 patients between 2000 and 2016 with HCC or CRLM undergoing major hepatectomy were extracted and analysed from a prospectively maintained database. PHLF was defined using the 50-50 criteria.
Liver cirrhosis and fatty liver were histologically confirmed in 35.6% and 53% of patients. 4.7% (n = 22) of patients had PHLF. A 90-day mortality was 5.1% (n = 24). Pre-operative albumin-bilirubin score (p = 0.0385), prothrombin time (p < 0.0001) and the natural logarithm of the ratio of post-operative day 1 to pre-operative serum bilirubin (SB) (ln(Bil/Bil); p < 0.0001) were significantly independent predictors of PHLF. The PHLF prognostic nomogram was developed using these factors with receiver operating curve showing area under curve of 0.88. Excellent sensitivity (94.7%) and specificity (95.7%) for the prediction of PHLF (50-50 criteria) were achieved at cut-offs of 9 and 11 points on this model. This score was also predictive of PHLF according to Bil > 7 and International Study Group for Liver Surgery criteria, intensive care unit admissions, length of stay, all complications, major complications, re-admissions and mortality (p < 0.05).
The PHLF nomogram ( https://tinyurl.com/SGH-PHLF-Risk-Calculator ) can serve as a useful tool for early identification of patients at high risk of PHLF before the 'point of no return'. This allows enforcement of closer monitoring, timely intervention and mitigation of adverse outcomes.
肝切除术(LR)是治疗肝细胞癌(HCC)和结直肠癌肝转移(CRLM)的主要方式。肝切除术后肝功能衰竭(PHLF)仍然是最可怕的并发症。我们旨在为接受 LR 的患者创建一个早期风险分层的预后评分。
从一个前瞻性维护的数据库中提取并分析了 2000 年至 2016 年间接受大肝切除术治疗 HCC 或 CRLM 的 472 名患者的临床和手术数据。使用 50-50 标准定义 PHLF。
35.6%和 53%的患者经组织学证实为肝硬化和脂肪肝。4.7%(n=22)的患者发生 PHLF。90 天死亡率为 5.1%(n=24)。术前白蛋白-胆红素评分(p=0.0385)、凝血酶原时间(p<0.0001)和术后第 1 天与术前血清胆红素(SB)的自然对数比(ln(Bil/Bil);p<0.0001)是 PHLF 的显著独立预测因子。该模型使用这些因素开发了 PHLF 预后列线图,ROC 曲线下面积为 0.88。在该模型上,截断值为 9 和 11 时,该模型对 PHLF(50-50 标准)的预测具有出色的敏感性(94.7%)和特异性(95.7%)。该评分还可预测 Bil>7 和国际肝脏外科研究组标准、入住重症监护病房、住院时间、所有并发症、主要并发症、再入院和死亡率的 PHLF(p<0.05)。
PHLF 列线图(https://tinyurl.com/SGH-PHLF-Risk-Calculator)可作为一种有用的工具,用于在“无法挽回”之前尽早识别 PHLF 风险较高的患者。这可以加强监测、及时干预和减轻不良后果。